Orchid Pharma has announced the listing and admission to dealings of a significant block of equity shares on the National Stock Exchange of India Limited and BSE Limited. These shares, totaling 4,45,86,052, were issued and allotted pursuant to the company’s scheme of amalgamation, which received sanction from the Hon’ble National Company Law Tribunal (NCLT), Chennai Bench. The listing became effective from September 23, 2026.
Equity Shares Listed on Exchanges
Orchid Pharma Limited has officially confirmed the listing and admission to dealings of a substantial number of equity shares on the National Stock Exchange of India Limited and BSE Limited. This development is a direct outcome of the company’s scheme of amalgamation.
Amalgamation Details and Share Allotment
In line with the company’s previous intimation dated August 01, 2026, a total of 4,45,86,052 equity shares have been issued and allotted. This allotment is a consequence of the amalgamation scheme that has been sanctioned by the Hon’ble National Company Law Tribunal (NCLT), Chennai Bench.
Effective Date of Trading
The newly allotted equity shares have been successfully listed and admitted to trading on both the National Stock Exchange of India Limited and BSE Limited. This listing is effective from September 23, 2026, marking a key milestone following the completion of the amalgamation process.
Kapil Dayya, Company Secretary & Compliance Officer, signed the intimation on behalf of Orchid Pharma Limited.
Source: BSE
